Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Indegene Limited ( (IN:INDGN) ) is now available.
Indegene Limited has announced the reappointment of three Independent Directors, Mr. Jairaj Manohar Purandare, Dr. Ashish Gupta, and Mr. Pravin Udhyavara Bhadya Rao, for a second term of five years. This decision, approved by the Board of Directors, is subject to shareholder approval through a postal ballot. Additionally, the Board has approved the allotment of equity shares under the RSU 2020 plan, which includes a bonus element. These strategic moves are expected to strengthen Indegene’s governance and support its growth initiatives, reinforcing its position in the healthcare industry.
More about Indegene Limited
Indegene Limited operates in the healthcare industry, providing technology-driven solutions and services to pharmaceutical companies and healthcare organizations. The company focuses on delivering innovative solutions to enhance healthcare delivery and patient outcomes.
YTD Price Performance: -13.70%
Average Trading Volume: 25,373
See more insights into INDGN stock on TipRanks’ Stock Analysis page.